These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24224012)

  • 21. Vegfa promoter gene hypermethylation at HIF1α binding site is an early contributor to CKD progression after renal ischemia.
    Sánchez-Navarro A; Pérez-Villalva R; Murillo-de-Ozores AR; Martínez-Rojas MÁ; Rodríguez-Aguilera JR; González N; Castañeda-Bueno M; Gamba G; Recillas-Targa F; Bobadilla NA
    Sci Rep; 2021 Apr; 11(1):8769. PubMed ID: 33888767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation and age-related downregulation of Klotho in rhesus monkey.
    King GD; Rosene DL; Abraham CR
    Age (Dordr); 2012 Dec; 34(6):1405-19. PubMed ID: 21922250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study.
    Kim HJ; Lee J; Chae DW; Lee KB; Sung SA; Yoo TH; Han SH; Ahn C; Oh KH
    BMC Nephrol; 2019 Apr; 20(1):119. PubMed ID: 30943913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease.
    Zhang Q; Liu L; Lin W; Yin S; Duan A; Liu Z; Cao W
    Kidney Int; 2017 Jan; 91(1):144-156. PubMed ID: 27692562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ratio of urinary TREM-1/TREM-2 mRNA expression in chronic kidney disease and renal fibrosis.
    Cao Y; Wang Y; Peng N; Xiao J; Wang S; Fu C
    Ann Med; 2021 Dec; 53(1):1010-1018. PubMed ID: 34176389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis.
    Yu Y; Guan X; Nie L; Liu Y; He T; Xiong J; Xu X; Li Y; Yang K; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Mol Med (Berl); 2017 Jun; 95(6):601-613. PubMed ID: 28508124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor Klotho KL-VS Polymorphism Predicts Allograft Glomerulosclerosis and Early Post-Transplant Kidney Function.
    Pazik J; Rembek K; Sadowska-Jakubowicz A; Sitarek E; Kosieradzki M; Durlik M
    Transplant Proc; 2020 Oct; 52(8):2371-2375. PubMed ID: 32571701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.
    Chen J; Zhang X; Zhang H; Liu T; Zhang H; Teng J; Ji J; Ding X
    Int J Biol Sci; 2016; 12(10):1236-1246. PubMed ID: 27766038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGCG Attenuates Renal Damage via Reversing Klotho Hypermethylation in Diabetic db/db Mice and HK-2 Cells.
    Yang XH; Zhang BL; Zhang XM; Tong JD; Gu YH; Guo LL; Jin HM
    Oxid Med Cell Longev; 2020; 2020():6092715. PubMed ID: 32908633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis.
    Sugiura H; Yoshida T; Shiohira S; Kohei J; Mitobe M; Kurosu H; Kuro-o M; Nitta K; Tsuchiya K
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1252-64. PubMed ID: 22338084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTSD and the klotho longevity gene: Evaluation of longitudinal effects on inflammation via DNA methylation.
    Wolf EJ; Logue MW; Zhao X; Daskalakis NP; Morrison FG; Escarfulleri S; Stone A; Schichman SA; McGlinchey RE; Milberg WP; Chen C; Abraham CR; Miller MW
    Psychoneuroendocrinology; 2020 Jul; 117():104656. PubMed ID: 32438247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Utility of Kidney Cortical Thickness in assessing severity of CKD in Low Income Setting.
    Uduagbamen PK; Odunlami OA; Yusuf AOA; Thompson MU; Ojo NK; Ajiboye OF; Ehioghae O; Oyewale DV
    West Afr J Med; 2021 Dec; 38(12):1224-1230. PubMed ID: 35037625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.
    Li J; Zhou C; Wang G; Wang S; Ni S; Ye M; Zhang J
    Gene; 2018 Feb; 644():74-79. PubMed ID: 29107007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic Regulation of KL (Klotho) via H3K27me3 (Histone 3 Lysine [K] 27 Trimethylation) in Renal Tubule Cells.
    Han X; Sun Z
    Hypertension; 2020 May; 75(5):1233-1241. PubMed ID: 32223380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between renal elasticity evaluated by Real-time tissue elastography and renal fibrosis.
    Makita A; Nagao T; Miyoshi KI; Koizumi Y; Kurata M; Kondo F; Shichijo S; Hirooka M; Yamaguchi O
    Clin Exp Nephrol; 2021 Sep; 25(9):981-987. PubMed ID: 33963937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRF-1 promotes renal fibrosis by downregulation of Klotho.
    Li Y; Liu Y; Huang Y; Yang K; Xiao T; Xiong J; Wang K; Liu C; He T; Yu Y; Han W; Wang Y; Bi X; Zhang J; Huang Y; Zhang B; Zhao J
    FASEB J; 2020 Mar; 34(3):4415-4429. PubMed ID: 31965641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
    Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.